Quetiapine and Clozapine in Parkinsonian Patients With Dopaminergic Psychosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goetz, 1993, Risk factors for nursing home placement in advanced Parkinsons disease., Neurology, 43, 2227, 10.1212/WNL.43.11.2227
Aarsland, 1999, Prevalence and clinical correlates of psychosis in Parkinsons disease., Arch Neurol, 56, 595, 10.1001/archneur.56.5.595
Fenelon, 2000, Hallucinations in Parkinsons disease: prevalence, phenomenology and risk factors., Brain, 123, 733, 10.1093/brain/123.4.733
Sanchez-Ramos, 1996, Visual hallucinations associated with Parkinsons disease., Arch Neurol, 53, 1265, 10.1001/archneur.1996.00550120077019
Shergill, 1998, A preliminary investigation of laterality in Parkinsons disease and susceptibility to psychosis., J Neurol Neurosurg Psychiatry, 65, 610, 10.1136/jnnp.65.4.610
Meco, 1990, Hallucinations in Parkinsons disease: neuropsychological study., Ital J Neurol Sci, 11, 374, 10.1007/BF02335940
Rondot, 1984, Mental disorders in Parkinsons disease after treatment with l-Dopa., Adv Neurol, 40, 259
Graham, 1997, Hallucinations in idiopathic Parkinsons disease., J Neurol Neurosurg Psychiatry, 63, 434, 10.1136/jnnp.63.4.434
de la Fuente-Fernandez R, Amparo Nunez, 1999, The apolipoprotein E4 allele increases the risk of drug-induced hallucinations in Parkinsons disease., Clin Neuropharmacol, 4, 226
Friedman, 2000, Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinsons disease., Mov Disord, 15, 201, 10.1002/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D
1999, Low-dose clozapine for the treatment of drug-induced psychosis in Parkinsons disease., N Engl J Med, 340, 757, 10.1056/NEJM199903113401003
1999, Clozapine in drug-induced psychosis in Parkinsons disease., Lancet, 353, 2041, 10.1016/S0140-6736(99)00860-0
Honigfeld, 1998, Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry., J Clin Psychiatry, 59, 3
Ellis, 2000, Clozapine and risperidone treatment of psychosis in Parkinsons disease., J Neuropsychiatry Clin Neurosci, 12, 364, 10.1176/jnp.12.3.364
Goetz, 2000, Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients., Neurology, 55, 789, 10.1212/WNL.55.6.789
Parsa, 1998, Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinsons disease., J Neuropsychiatry Clin Neurosci, 10, 216, 10.1176/jnp.10.2.216
Fernandez, 1999, Quetiapine for the treatment of drug-induced psychosis in Parkinsons disease., Mov Disord, 14, 484, 10.1002/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B
Menza, 1999, Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinsons disease., Ann Clin Psychiatry, 11, 141, 10.3109/10401239909147063
Targum, 2000, Efficacy of quetiapine in Parkinsons patients with psychosis., J Clin Psychopharmacol, 20, 54, 10.1097/00004714-200002000-00010
Dewey, 2000, Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinsons disease., Neurology, 55, 1753, 10.1212/WNL.55.11.1753
Goldstein, 1995, ICI 204,636 (Seroquel): a dibenzothiazepine atypical antipsychotic: review of pre-clinical pharmacology and highlights of phase II clinical trials., CNS Drug Rev, 1, 50, 10.1111/j.1527-3458.1995.tb00276.x
Gelb, 1999, Diagnostic criteria for Parkinsons disease., Arch Neurol, 56, 33, 10.1001/archneur.56.1.33
Juncos, 1998, Long-term effects of quetiapine fumarate in parkinsonism complicated by psychosis., Neurology, 50, 70
Brandstadter, 2002, Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinsons disease., Neurology, 58, 160, 10.1212/WNL.58.1.160-a
Tamminga, 1994, Clozapine in tardive dyskinesia: observations from human and animal model studies., J Clin Psychiatry, 55, 102